Fmr LLC Cytek Biosciences, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Fmr LLC holds 636,690 shares of CTKB stock, worth $4.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

636,690

Previous 522,388 21.88%

Holding current value

$4.6 Million

Previous $3.51 Million 1.34%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.3 - $6.91 $605,800 - $789,826	114,302 Added 21.88%	636,690 $3.55 Million
Q1 2024 May 13, 2024	SELL	$6.29 - $9.15 $144 - $210	-23 Reduced -0.0%	522,388 $3.51 Million
Q4 2023 Feb 13, 2024	BUY	$4.1 - $9.51 $10,938 - $25,372	2,668 Added 0.51%	522,411 $4.76 Million
Q3 2023 Nov 13, 2023	BUY	$5.52 - $9.5 $2,070 - $3,562	375 Added 0.07%	519,743 $2.87 Million
Q2 2023 Aug 11, 2023	BUY	$6.69 - $11.99 $8,081 - $14,483	1,208 Added 0.23%	519,368 $4.44 Million
Q1 2023 May 11, 2023	SELL	$8.44 - $13.47 $147,708 - $235,738	-17,501 Reduced 3.27%	518,160 $4.76 Million
Q4 2022 Feb 13, 2023	SELL	$9.71 - $15.86 $576,890 - $942,274	-59,412 Reduced 9.98%	535,661 $5.47 Million
Q3 2022 Nov 10, 2022	BUY	$10.96 - $15.45 $813,538 - $1.15 Million	74,228 Added 14.25%	595,073 $8.76 Million
Q2 2022 Aug 12, 2022	BUY	$7.41 - $11.56 $19,384 - $30,240	2,616 Added 0.5%	520,845 $5.59 Million
Q1 2022 May 13, 2022	SELL	$9.89 - $17.25 $21.2 Million - $37.1 Million	-2,148,371 Reduced 80.57%	518,229 $5.59 Million
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $46.7 Million - $74.5 Million	2,666,600 New	2,666,600 $57.1 Million

Others Institutions Holding CTKB

# of Institutions

132

Shares Held

74M

Call Options Held

200

Put Options Held

100

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $972M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account